Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.

Clinical Trial ID NCT03491696

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03491696

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Epigenetic programming by maternal behavior.	Nat Neurosci	2004	20.92
2	Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.	Br J Psychiatry	2001	4.33
3	Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.	Biol Psychiatry	2001	3.39
4	Mood disorders and allostatic load.	Biol Psychiatry	2003	3.23
5	A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.	Arch Gen Psychiatry	1981	2.76
6	Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.	Psychosom Med	2011	2.30
7	The DST as a predictor of outcome in depression: a meta-analysis.	Am J Psychiatry	1993	1.95
8	Do corticosteroids damage the brain?	J Neuroendocrinol	2006	1.64
9	Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.	Arch Gen Psychiatry	2004	1.63
10	Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.	Lancet Psychiatry	2015	1.42
11	Not fade away: the HPA axis and depression.	Psychol Med	2010	0.99
12	Antiglucocorticoid treatments for mood disorders.	Cochrane Database Syst Rev	2008	0.96
13	Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.	Psychiatr Danub	2013	0.82
14	Neuroendocrine profiles in mood disorders.	Int J Neuropsychopharmacol	2003	0.82
15	Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.	Pol J Pharmacol	2005	0.79
16	Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.	Can J Psychiatry	1998	0.76
17	Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients.	Psychoneuroendocrinology	2017	0.75
18	Genomic and epigenomic mechanisms of glucocorticoids in the brain.	Nat Rev Endocrinol	2017	0.75